首页> 外国专利> COMPOSITIONS AND METHODS FOR CANCER TREATMENT BY ENHANCING ANTITUMOR IMMUNITY USING TANNIC ACID-BASED NANOCAPSULES

COMPOSITIONS AND METHODS FOR CANCER TREATMENT BY ENHANCING ANTITUMOR IMMUNITY USING TANNIC ACID-BASED NANOCAPSULES

机译:通过使用鞣酸纳米胶囊提高抗肿瘤免疫性来治疗癌症治疗的组合物和方法

摘要

The present disclosure generally relates to a composition matter and a method for cancer treatment comprising albumin (alb) coated tannic acid-Fe nanoparticles (NPs) with a therapeutic compound, and one or more diluents, excipients or carriers. In particular, the present invention provides a treatment by enhancing antitumor immunity using tannic acid-based nanoparticles containing a therapeutic cancer treatment that can induce immunogenic cell death (ICD). The method disclosed herein provides a potential solution to the immunotoxicity accompanying the ICD cancer immunotherapy by intratumoral or intravenous administration of a nanocapsule formulation of carfilzomib (CFZ), an ICD-inducing proteasome inhibitor, using interfacial supramolecular assembly of tannic acid (TA) and iron, supplemented with albumin coating for better metabolic stability.
机译:本公开一般涉及组合物质和用于用治疗化合物和一种或多种稀释剂,赋形剂或载体的白蛋白(ALB)涂覆的单宁酸-Fe纳米颗粒(NPS)的组合物质和癌症处理方法。特别地,本发明提供了通过使用含有含有含有治疗性癌症治疗的营养性癌症治疗(ICD)来提高抗肿瘤免疫性来治疗抗肿瘤免疫。本文公开的方法通过脑内或静脉施用纳米胶(CFZ),ICD诱导蛋白酶体抑制剂的纳米胶囊制剂,使用单宁酸(TA)和铁的intercaceolulary组件,提供了伴随ICD癌症免疫疗法的免疫毒性的潜在溶液。 ,补充了白蛋白涂层,以便更好地代谢稳定性。

著录项

  • 公开/公告号WO2021050799A1

    专利类型

  • 公开/公告日2021-03-18

    原文格式PDF

  • 申请/专利权人 PURDUE RESEARCH FOUNDATION;

    申请/专利号WO2020US50284

  • 发明设计人 YEO YOON;TAHA MAIE S.;

    申请日2020-09-11

  • 分类号A61K38/07;A61K9/51;A61K47/10;A61K47/42;A61P35;

  • 国家 US

  • 入库时间 2022-08-24 17:48:57

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号